Description

Product Description

Palmitoyl tripeptide-8 is a synthetic bioactive peptide consisting of a tripeptide sequence conjugated to palmitic acid, which enhances its lipophilicity and dermal penetration. It has gained recognition in cosmetic peptide research due to its potent soothing and anti-inflammatory properties, particularly for sensitive and reactive skin models. This peptide acts as a molecular messenger that helps restore the skin’s equilibrium by reducing neurogenic inflammation and mitigating histamine-induced reactions.

In sensitive or stressed skin, the immune response often becomes dysregulated, leading to redness, itching, or discomfort. Palmitoyl tripeptide-8 plays a key role in regulating these immune-mediated responses by modulating cytokine release from keratinocytes and immune cells. Studies have shown that this peptide helps decrease the secretion of pro-inflammatory markers such as interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor-alpha (TNF-α), which are commonly associated with irritation and sensitivity.

The peptide’s mechanism is particularly relevant for research exploring the link between neurogenic inflammation and skin barrier dysfunction. By interacting with neuronal communication pathways and inhibiting the release of substance P—a neuropeptide known to trigger inflammation—Palmitoyl tripeptide-8 helps to reduce vasodilation and local swelling. This mechanism contributes to its visible soothing and anti-redness effects in laboratory skin models.

In cosmetic research, Palmitoyl tripeptide-8 is frequently combined with antioxidants and barrier-supporting peptides to develop formulations for post-procedure care, anti-stress creams, and sensitive-skin serums. Its lipid tail, palmitic acid, ensures enhanced skin absorption, allowing efficient delivery to deeper skin layers where inflammatory signaling occurs.

Due to its biocompatibility, stability, and ease of formulation, Palmitoyl tripeptide-8 has become a preferred ingredient for studies targeting the reduction of irritation caused by UV exposure, pollution, or aggressive cosmetic actives. It is also used to investigate peptide-based approaches for reinforcing the skin’s natural resilience and comfort, especially in subjects with reactive or redness-prone skin.

Product Specifications

Mechanism of Action

Palmitoyl tripeptide-8 functions through a multifaceted mechanism targeting both neurogenic and immune-mediated inflammation. It helps normalize overactive immune signaling and restores balance to the skin’s defense system.

1. Neurogenic Inflammation Suppression

The peptide inhibits the release of substance P and calcitonin gene-related peptide (CGRP), both of which trigger vasodilation and erythema. By modulating these neuropeptides, it effectively calms reactive skin and reduces redness in sensitive models.

2. Cytokine Modulation

Palmitoyl tripeptide-8 downregulates pro-inflammatory cytokines such as IL-6, IL-8, and TNF-α while upregulating anti-inflammatory mediators like IL-10. This dual regulation contributes to maintaining skin homeostasis and comfort.

3. Mast Cell Stabilization

Histamine release from mast cells is a key cause of itching and redness. The peptide has been observed to stabilize mast cell membranes, preventing excessive histamine discharge and reducing discomfort.

4. Barrier Function Support

By promoting the synthesis of ceramides and other barrier lipids, Palmitoyl tripeptide-8 enhances the skin’s ability to retain moisture and resist environmental aggressors. This supports its use in formulations for sensitive or post-treatment skin.

5. Synergy with Other Peptides

When combined with Palmitoyl Tetrapeptide-7 or Acetyl Hexapeptide-37, it exhibits synergistic effects in reducing inflammation and reinforcing barrier integrity. Research indicates these combinations are effective in multi-target anti-irritation peptide complexes.

Side Effects

Under controlled laboratory research conditions, Palmitoyl tripeptide-8 exhibits excellent safety and compatibility with human skin models. It shows low cytotoxicity and minimal risk of irritation, even at higher research concentrations.

No significant adverse effects have been reported in in-vitro or ex-vivo skin testing. However, as with all peptide materials, formulation pH, solvent type, and concentration can influence biocompatibility. It is recommended that researchers conduct patch compatibility tests when developing new formulations.

The peptide should not be ingested or injected and must be used strictly for laboratory or formulation research purposes.

Keywords

Palmitoyl tripeptide-8, anti-allergen peptide, sensitive skin peptide, anti-redness peptide, cosmetic peptide supplier, high-purity cosmetic peptides, peptide wholesale China, OEM peptide production, peptide manufacturer, high purity peptide powder

Shipping Guarantee

All Palmitoyl Tripeptide-8 shipments are handled using validated cold-chain logistics to preserve peptide integrity. Each package is sealed in moisture-proof containers with secondary protective wrapping and continuous temperature monitoring. Products are shipped via express international couriers with full tracking and insurance coverage.

Trade Assurance

We Palmitoyl Tripeptide-8 ensure product authenticity, verified ≥99% purity, and compliance with analytical standards (HPLC, MS, and NMR). Each batch is supplied with a Certificate of Analysis (CoA). Our trade assurance policy guarantees replacement or refund for any deviation from listed specifications.

Payment Support

We Palmitoyl Tripeptide-8 provide flexible and secure global payment options to support international research transactions. Accepted payment methods include PayPal, major credit cards (Visa, MasterCard, American Express), telegraphic transfer (T/T), and cryptocurrencies (USDT, Bitcoin, Ethereum). All transactions are protected by industry-standard encryption and verified payment gateways to ensure confidentiality and fund security.

Disclaimer

All Palmitoyl Tripeptide-8 products listed are intended for laboratory research use only and not for human or veterinary use. They are not drugs, medical devices, or diagnostics and should not be administered to humans or animals. Researchers must handle all materials in accordance with institutional biosafety and chemical safety guidelines. The information provided is for scientific reference only and does not imply therapeutic efficacy, safety, or regulatory approval.